| Literature DB >> 22701617 |
Spencer V Nyholm1, Pengfei Song, Jeanne Dang, Corey Bunce, Peter R Girguis.
Abstract
The relationships between hydrothermal vent tubeworms and sulfide-oxidizing bacteria have served as model associations for understanding chemoautotrophy and endosymbiosis. Numerous studies have focused on the physiological and biochemical adaptations that enable these symbioses to sustain some of the highest recorded carbon fixation rates ever measured. However, far fewer studies have explored the molecular mechanisms underlying the regulation of host and symbiont interactions, specifically those mediated by the innate immune system of the host. To that end, we conducted a series of studies where we maintained the tubeworm, Ridgeia piscesae, in high-pressure aquaria and examined global and quantitative changes in gene expression via high-throughput transcriptomics and quantitative real-time PCR (qPCR). We analyzed over 32,000 full-length expressed sequence tags as well as 26 Mb of transcript sequences from the trophosome (the organ that houses the endosymbiotic bacteria) and the plume (the gas exchange organ in contact with the free-living microbial community). R. piscesae maintained under conditions that promote chemoautotrophy expressed a number of putative cell signaling and innate immunity genes, including pattern recognition receptors (PRRs), often associated with recognizing microbe-associated molecular patterns (MAMPs). Eighteen genes involved with innate immunity, cell signaling, cell stress and metabolite exchange were further analyzed using qPCR. PRRs, including five peptidoglycan recognition proteins and a Toll-like receptor, were expressed significantly higher in the trophosome compared to the plume. Although PRRs are often associated with mediating host responses to infection by pathogens, the differences in expression between the plume and trophosome also implicate similar mechanisms of microbial recognition in interactions between the host and symbiont. We posit that regulation of this association involves a molecular "dialogue" between the partners that includes interactions between the host's innate immune system and the symbiont.Entities:
Mesh:
Year: 2012 PMID: 22701617 PMCID: PMC3372519 DOI: 10.1371/journal.pone.0038267
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of transcriptome sequencing of the trophosome (EST) and the plume (454 pyrosequencing) from Ridgeia piscesae.
| TROPHOSOME | |
|
| 32, 256 |
| Average EST length | 582 bp |
|
| 26, 355 |
|
| |
| ESTs with no hits | 21, 327 |
| ESTs with hits | 5, 028 |
|
| 8 |
|
| 38 |
|
| 4,971 |
|
| 5,824 |
| Total bases | 3.9 Mb |
| Average sequence length | 672 bp |
| Average percent GC | 0.46 (+/−0.08) |
|
| |
|
| 918, 215 |
| Total bases | 363.6 Mb |
| Average read length | 396 bp |
|
| 20, 757 |
| Total bases | 26.5 Mb |
| Average length | 1,279 bp |
| Range of contig length | 50–12,251 bp |
| Average percent GC | 0.47 |
analysis of Trimmed Unique ESTs.
Trophosome and plume sequences from Ridgeia piscesae.
| Category | Putative Identification | E-Value | Organism | GenBank Accession Number | Tissue Database |
| MAMP recognition | |||||
| Peptidoglycan recognition protein 3 precursor (RpiPGRP1) | 1.00E-30 |
| AY956813 | T | |
| PGRP SC3 precursor (RpiPGRP2) | 9.00E-15 |
| FJ829250 | B | |
| PGRP 2 (RpiPGRP3) | 7.00E-10 |
| Q8VCS0 | P | |
| PGRP S1S (RpiPGRP4) | 6.00E-12 |
| AB425335 | P | |
| PGRP-LE (RpiPGRP5) | 1.00E-26 |
| AF313391 | P | |
| Macrophage mannose receptor 1-like protein 1 | 8.00E-11 |
| Q5VSK2 | B | |
| Lipoprotein receptor-related protein | 2.00E-22 |
| Q9NZR2 | B | |
| Toll-like receptor 2 precursor | 8.00E-07 |
| Q9R1F8 | B | |
| Galectin | 3.00E-38 |
| XM_002731539 | P | |
| Immune Signaling | |||||
| NF-κB inhibitor (cactus) | 6.00E-14 |
| Q03017 | B | |
| NF-κB inhibitor (I kappa-B alpha) | 5.00E-13 |
| Q91974 | B | |
| NF-κB inhibitor epsilon (I kappa-B-epsilon) | 3.00E-13 |
| Q54910 | P | |
| NF-κB repressing factor | 7.00E-12 |
| Q8BY02 | B | |
| B-cell receptor associated protein (Bap31) | 6.00E-46 |
| Q5R8H3 | B | |
| Lipopolysaccharide-induced tumor necrosis factor-alpha | 3.00E-15 |
| Q8QGW7 | B | |
| Notch 1 | 1.00E-71 |
| Q5BJL5 | B | |
| Macrophage migration inhibitory factor | 4.00E-28 |
| A9JSE7 | P | |
| Cell cycling/Apoptosis | |||||
| Ubiquitin | 4.00E-19 |
| P14792 | B | |
| dnaJ (apoptosis) | 1.00E-108 |
| P59910 | B | |
| skpA | 2.00E-29 |
| NM166861 | B | |
| MADS-box | 3.00E-12 |
| DQ512346.1 | B | |
| T-complex protein 1 | 7.00E-25 |
| Q5XIM9 | B | |
| Zonadehsin precursor | 1.00E-12 |
| O88799 | B | |
| GRIM 19 cell death regulatory protein | 4.00E-22 |
| Q95KV7 | B | |
| DAD-1 defender against cell death | 4.00E-41 |
| Q9VLM5 | B | |
| LITAF-like cell death inducing protein | 2.00E-15 |
| Q9H305 | B | |
| Apoptosis-inducing factor 1 | 1.00E-136 |
| O95831 | P | |
| Programmed cell death 6 | 2.00E-61 |
| P12815 | P | |
| Cytokine induced apoptosis inhibitor 1 | 2.00E-69 |
| Q5EAC7 | P | |
| BCL2-antagonist/killer | 4.00E-30 |
| O08734 | P | |
| BIRC4 | 9.00E-50 |
| Q9R0I6 | P | |
| Tumor response | |||||
| Tumor suppressor candidate 3 | 1.00E-120 |
| Q13454 | B | |
| Translationally-controlled tumor protein homolog (TCTP) | 4.00E-61 |
| O18477 | B | |
| Cell stress mediators | |||||
| BAT1 ATP-dependent helicase (inflammation) | 5.00E-29 |
| AF075691.1 | B | |
| Heat shock protein 10(mitochondrial) | 3.00E-30 |
| P26772 | B | |
| Heat shock protein 70 | 1.00E-138 |
| P27420 | B | |
| Heat shock protein 75 | 1.00E-28 |
| Q9CQN1 | B | |
| Heat shock protein 90 | 1.00E-176 |
| P14625 | B | |
| Heat shock protein betat1 | 1.00E-22 |
| Q00649 | B | |
| Stress-induced protein SAM-22 | 1.00E-22 |
| P26987 | T | |
| Zinc finger stress associated protein | 2.00E-14 |
| Q7Y1W9 | B | |
| Immunoglobulin superfamily | |||||
| Alpha-2 macroglobulin receptor | 9.00E-13 |
| Q91ZX7 | B | |
| Alpha-2 macroglobulin receptor associated protein | 3.00E-28 |
| P30533 | B | |
| Plasminogen precursor | 5.00E-52 |
| O18783 | B | |
| Growth and differentiation factor-associated serum protein | 7.00E-10 |
| Q7TQN3 | B | |
| Leucine-rich repeat and IG-like nogo receptor | 1.00E-12 |
| Q3URE9 | P | |
| Miscellaneous immune/defense-related domains | |||||
| Sushi EGF domain-containing protein | 3.00E-51 |
| Q70E20 | B | |
| DC-Sign C-type lectin | 1.00E-09 |
| Q8CJ91 | B | |
| Lipopolysaccharide-induced TNF alpha | 3.00E-15 |
| Q8QGW7 | B | |
| Disease-resistance protein | 2.00E-14 |
| P14710 | T | |
| Bactericidal permeability increasing protein | 4.00E-37 |
| P17213 | P | |
| Autophagy related 5 homolog | 5.00E-75 |
| Q3MQ04 | P | |
| Reactive oxygen species modulator 1 | 4.00E-24 |
| Q4V7T9 | P |
Genes previously reported as being expressed in the trophosome [40].
ESTs contigs and 454 isotigs were identified using the BLAST-based analysis program BLASTX (National Center for Bioinformatics Information; NCBI; [85], which compared our sequence to six non-redundant peptide sequence databases (GenBank CDS translations, RefSeq Proteins, PDB, SwissProt, PIR, and PRF). Sequences with E values of <10–6 were categorized and quantified according to the functional category of the homologous gene. Source sequence tissue databases are: T, Trophosome; P, Plume; B, Both.
Characteristics of putative Ridgeia piscesae PGRP peptides.
| PGRP | Organism | E-Value | Domains | Predicted Localization | ||
| SP | TM | PGRP | ||||
| Rpi1 |
| 1e-30 | X | X | X | Extracellular (secreted) |
| Rpi2 |
| 1e-53 | X | X | Extracellular (secreted) | |
| Rpi3 |
| 7e-10 | X | Cytoplasmic and Nuclear | ||
| Rpi4 |
| 6e-11 | X | X | X | Extracellular (secreted) |
| Rpi5 |
| 3e-31 | X | X | Cytoplasmic and Plasma Membrane | |
Peptide sequences were predicted for the 5 putative PGRP ESTs using NCBI’s ORF Finder analysis tool. The sequences were then analyzed using BLASTP, against the non-redundant (nr) protein database to find top hits. The organism and E-value of the top PGRP homolog found for each is presented. Protein domains were predicted for the peptides using InterProScan (EMBL-EBI), and are as follows: SP = signal peptide, TM = transmembrane, and PGRP = peptidoglycan recognition protein domain. An X means the domain was found in the protein sequence. Cellular localization for each peptide was predicted using the WoLF PSORT prediction server [86].
Figure 1Box plot showing expression of target genes in the trophosome compared to the plume as determined by qPCR.
The fold expression level differences, of 18 target genes, in the trophosome were compared to those of the plume. The upper and lower ends of the boxes indicate the 25th and 75th percentiles, respectively. The length of the box depicts the interquartile range within which 50% of the values are located. The solid black lines denote the median. Capped error bars represent the minimum and maximum values, excluding outliers (Table 4). The dotted black line represents expression levels in the plume (y = 1), thus genes with medians >1 exhibit higher expression levels in the trophosome compared to the plume, and inversely genes with medians <1 show higher expression levels in the plume. All expression levels are normalized to the expression of actin. The gene abbreviations are as follows: hbB1, hemoglobin B1; HSP70, heat shock protein 70; LITAF, lipopolysaccharide-induced tumor necrosis factor-alpha; PGRPrpi1–5, peptidoglycan recognition protein 1–5; TLR2p, toll-like receptor 2 precursor; A2MRAP, alpha-2 macroglobulin receptor associated protein; CAbr, carbonic anhydrase (branchial plume); CAtr, carbonic anhydrase (trophosome); EF1α, elongation factor 1-alpha; LBPIP, LPS induced bactericidal permeability increasing protein; MMIF, macrophage migration inhibitory factor; MR, macrophage mannose receptor 1-like protein; NF-κBic, NF-κB inhibitor (cactus); ROSm, reactive oxygen species modulator.
Targeted gene expression for individual worms.
| Target Gene | Individual | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | |
|
| 206.52 | 38.05 | 41.66 | 58.37 | 66.36 |
|
|
| 18.28 |
| 1.31 | 6.19 | 12.47 | 3.45 |
|
| 4.49 | 1.89 | 12.87 | 0.93 | 0.04 |
|
|
| 2.75 |
| 1.54 | 51.09 | 39.68 | 1.54 |
|
| 4.45 | 0.43 |
| 77.78 | 11.77 | 64.00 |
|
| 19.17 | 4.61 | 100.98 | 3.09 | 0.28 |
|
|
| 0.15 | 2.41 | 1.35 | 0.95 | 20.63 | 24.66 |
|
| 6.66 | 0.48 | 21.71 | 2.83 | 0.83 | 31.50 |
|
| 1.16 | 0.30 | 6.03 | 1.18 | 0.99 |
|
|
| 0.11 | 0.02 | 0.08 | 0.01 | 0.01 | 0.14 |
|
| 2.55 | 4.70 | 8.34 | 10.30 | 3.17 | 8.16 |
|
| 0.58 | 0.14 | 0.23 | 0.34 | 0.27 |
|
|
| 1.17 | 0.13 | 1.33 | 2.18 | 0.26 |
|
|
| 0.20 | 2.46 | 0.20 | 0.13 |
| 0.57 |
|
| 0.01 | 0.20 | 0.01 | 0.02 |
| 0.01 |
|
| 1.93 | 2.27 | 8.95 | 2.92 | 0.13 |
|
|
| 6.09 | 3.64 | 3.80 | 0.23 | 5.58 |
|
|
| 0.73 | 0.90 | 1.23 | 1.09 | 0.61 |
|
Values are fold change calculated with the 2–ΔΔCt method and normalized to actin in trophosome compared to plume. Outliers are shown in italics (see Materials and Methods ).
Figure 2Model of host-symbiont interactions between pattern recognition receptors (PRRs) and microbe-associated molecular patterns (MAMPs) in R. piscesae.
The branchial plume (p) of Ridgeia exchanges metabolites with the environment. The plume lacks symbionts but may still use PRRs to interact with microorganisms found in the surrounding vent fluid and seawater. The center of the worm is comprised mainly of one organ, the trophosome (t) made up of lobules that contain bacteriocytes housing the intracellular bacterial symbionts (endosymbionts) as well as blood vessels (bv) that transfer metabolites. Central bacteriocytes (c) harbor healthy and actively dividing endosymbionts. Towards the periphery of the lobules, bacteriocytes and symbionts appear to undergo terminal differentiation and apoptosis with many of the degenerative symbionts undergoing autophagy. We suggest a significantly greater response of the trophosome to MAMPs via PRRs that may trigger signal transduction cascades, ultimately helping to regulate symbiostasis. PRR expression in the trophosome may occur in the bacteriocytes and/or in the surrounding vasculature. Given the densities of endosymbionts, bacteriocytes encounter high concentrations of MAMPs. A constant turnover of bacteriocytes may also release extracellular MAMPs into the trophosome periphery.